DANAHER CORP /DE/ - 17 Jun 2021 Form 3/A - Amendment Insider Report for Codex DNA, Inc. (TBIO)

Role: 10%+ Owner
Signature: Danaher Corporation /s/ James F. O'Reilly, Vice President, Deputy General Counsel and Secretary
Issuer symbol: TBIO
Transactions as of: 17 Jun 2021
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 24 Jun 2021, 16:50:58 UTC
Date Of Original Report: 17 Jun 2021
Next filing: 24 Jun 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TBIO	Series A Preferred Stock							17 Jun 2021	Common Stock	1,751,999		By Danaher Innovation Center LLC	F1, F2
holding	TBIO	Series A-1 Preferred Stock							17 Jun 2021	Common Stock	542,158		By Danaher Innovation Center LLC	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All shares of the preferred stock, par value $0.0001 per share, of the Issuer will automatically be converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), prior to the closing of the Issuer's initial public offering of its Common Stock.
F2	Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.